Nuveen
AHCO icon

Nuveen’s AdaptHealth AHCO Stock Holding History

Nuveen’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Buy
293,500
+5,779
+2% +$64.5K ﹤0.01% 2364
2026
Q1 		$3.42M Buy
287,721
+8,268
+3% +$84.6K ﹤0.01% 2053
2025
Q4 		$2.78M Buy
279,453
+3,245
+1% +$31K ﹤0.01% 2156
2025
Q3 		$2.47M Buy
276,208
+7,390
+3% +$68.4K ﹤0.01% 2217
2025
Q2 		$2.53M Sell
268,818
-47,363
-15% -$418K ﹤0.01% 2195
2025
Q1 		$3.43M Buy
316,181
+73
+0% +$734 ﹤0.01% 2106
2024
Q4 		$3.01M Buy
316,108
+69,050
+28% +$699K ﹤0.01% 2218
2024
Q3 		$2.77M Sell
247,058
-90,018
-27% -$957K ﹤0.01% 2265
2024
Q2 		$3.37M Buy
337,076
+11,275
+3% +$115K ﹤0.01% 2133
2024
Q1 		$3.75M Sell
325,801
-4,550
-1% -$38.6K ﹤0.01% 2121
2023
Q4 		$2.41M Buy
330,351
+77,201
+30% +$609K ﹤0.01% 2325
2023
Q3 		$2.3M Buy
253,150
+45,948
+22% +$551K ﹤0.01% 2237
2023
Q2 		$2.52M Sell
207,202
-68,914
-25% -$768K ﹤0.01% 2245
2023
Q1 		$3.43M Sell
276,116
-122,810
-31% -$2.26M ﹤0.01% 2096
2022
Q4 		$7.67M Sell
398,926
-238,631
-37% -$5.05M ﹤0.01% 1666
2022
Q3 		$12M Buy
637,557
+28,867
+5% +$593K ﹤0.01% 1360
2022
Q2 		$11M Buy
608,690
+254,254
+72% +$4.13M ﹤0.01% 1441
2022
Q1 		$6.12M Buy
354,436
+947
+0.3% +$17K ﹤0.01% 1950
2021
Q4 		$8.65M Buy
353,489
+15,733
+5% +$369K ﹤0.01% 1784
2021
Q3 		$7.87M Sell
337,756
-55,138
-14% -$1.33M ﹤0.01% 1954
2021
Q2 		$10.8M Buy
392,894
+74,284
+23% +$2.12M ﹤0.01% 1822
2021
Q1 		$11.7M Buy
318,610
+213,354
+203% +$7.54M ﹤0.01% 1699
2020
Q4 		$3.95M Buy
105,256
+8,151
+8% +$252K ﹤0.01% 2190
2020
Q3 		$2.12M Buy
97,105
+84,597
+676% +$1.78M ﹤0.01% 2355
2020
Q2 		$201K Buy
+12,508
New +$209K ﹤0.01% 3103

Other funds holding AHCO

OCA
OEP Capital Advisors New York $170M AUM 10.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $94.1M AUM 10.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen's AHCO Position: Q2 2026 in Review

Nuveen increased its AdaptHealth (AHCO) stake by 2% in Q2 2026, buying an estimated $64.5K and bringing the position to 293,500 shares worth $3.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2364.

Nuveen first reported a position in AHCO in Q2 2020 and has held it in 25 quarters since. The position peaked at $12M in Q3 2022. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Nuveen held 293,500 shares of AdaptHealth worth $3.06M as of Q2 2026.
  • Nuveen bought 5,779 AdaptHealth shares in Q2 2026, an estimated $64.5K.
  • AdaptHealth made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2364 holding.
  • Nuveen first reported a position in AdaptHealth in Q2 2020 and has held it in 25 quarters since.
  • Nuveen's AdaptHealth position peaked at $12M in Q3 2022.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.